YBEY and neoplasm: At the same time, this anti-tumor effect was found to be unaffected by double point mutations in the catalytic site of the targeted putative ribonuclease, as inactivation of the T2 enzyme by mutation or denaturation did not block the tested anticancer effect [14, 30].